Cost of Hospital-Acquired Infection

Abstract The authors assessed the costs of hospital-acquired infections using rigorous econometric methods on publicly available data, controlling for the interdependency of length of stay and the incidence of hospital acquired infection, and estimated the cost shares of different payers. They developed a system of equations involving length of stay, incidence of infection, and the total hospital care cost to be estimated using simultaneous equations system. The main data came from the State of New Jersey UB 92 for 2004, complimented with data from the Annual Survey of Hospitals by the American Hospital Association and the Medicare Cost Report of 2004. The authors estimated that an incidence of hospital acquired infection increases the hospital care cost of a patient by $10,375 and it increases the length of stay by 3.30 days, and that a disproportionately higher portion of the cost is attributable to Medicare. They conclude that reliable cost estimates of hospital-acquired infections can be made using publicly available data. Their estimate shows a much larger aggregate cost of $16.6 billion as opposed to $5 billion reported by the Centers for Disease Control and Prevention but much less than $29 billion as reported elsewhere in the literature.

[1]  H. Elder,et al.  Nosocomial infection surveillance. , 1979, QRB. Quality review bulletin.

[2]  G. Oster,et al.  Is sepsis accurately coded on hospital bills? , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[3]  R. Haley Measuring the costs of nosocomial infections: methods for estimating economic burden on the hospital. , 1991, The American journal of medicine.

[4]  M. Schumacher,et al.  Estimation of extra hospital stay attributable to nosocomial infections: heterogeneity and timing of events. , 2000, Journal of clinical epidemiology.

[5]  Marlene R. Miller,et al.  Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. , 2003, JAMA.

[6]  Peter Buerhaus,et al.  Nurse-staffing levels and the quality of care in hospitals. , 2002, The New England journal of medicine.

[7]  J. A. N. Eedleman,et al.  Nurse-Staffing Levels and the Quality of Care in Hospitals , 2002 .

[8]  Bob S. Carter,et al.  The Nationwide Inpatient Sample , 2008 .

[9]  W. Greene,et al.  计量经济分析 = Econometric analysis , 2009 .

[10]  A V Swan,et al.  The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. , 2001, The Journal of hospital infection.

[11]  R. Rubin,et al.  The economic impact of Staphylococcus aureus infection in New York City hospitals. , 1999, Emerging infectious diseases.

[12]  Elaine Larson,et al.  A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990-2000. , 2002, American journal of infection control.

[13]  R. Haley,et al.  The nationwide nosocomial infection rate. A new need for vital statistics. , 1985, American journal of epidemiology.

[14]  L J Carbary,et al.  Hospital-acquired infections. , 1975, Nursing care.

[15]  Elder Ha,et al.  Nosocomial infection surveillance. , 1979 .

[16]  David W. Bates,et al.  The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group , 1997 .

[17]  P. Maurette,et al.  [To err is human: building a safer health system]. , 2002, Annales francaises d'anesthesie et de reanimation.

[18]  A. Wall,et al.  Book ReviewTo Err is Human: building a safer health system Kohn L T Corrigan J M Donaldson M S Washington DC USA: Institute of Medicine/National Academy Press ISBN 0 309 06837 1 $34.95 , 2000 .

[19]  M. Kilgore,et al.  The Costs of Nosocomial Infections , 2008, Medical care.

[20]  D. Bates,et al.  The Costs of Adverse Drug Events in Hospitalized Patients , 1997 .

[21]  J. Hughes,et al.  The financial incentive for hospitals to prevent nosocomial infections under the prospective payment system. An empirical determination from a nationally representative sample. , 1987, JAMA.

[22]  R. Wenzel Nosocomial infections, diagnosis-related groups, and study on the efficacy of nosocomial infection control. Economic implications for hospitals under the prospective payment system. , 1985, The American journal of medicine.

[23]  Richard Platt,et al.  Using Automated Health Plan Data to Assess Infection Risk from Coronary Artery Bypass Surgery , 2002, Emerging infectious diseases.

[24]  D. Feingold,et al.  Hospital-acquired infections. , 1970 .

[25]  R. Haley,et al.  The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. , 1985, American journal of epidemiology.

[26]  R. Wenzel,et al.  A Prospective Study of Outcomes, Healthcare Resource Utilization, and Costs Associated With Postoperative Nosocomial Infections , 2006, Infection Control & Hospital Epidemiology.

[27]  E. Larson,et al.  Comparisons of health care-associated infections identification using two mechanisms for public reporting. , 2007, American journal of infection control.

[28]  Jennifer A. Roberts,et al.  Correcting for bias when estimating the cost of hospital-acquired infection: an analysis of lower respiratory tract infections in non-surgical patients. , 2005, Health economics.